|
Complainant part is expected to be returned for manufacturer review/investigation, but has yet to be received.Reporter is synthes sales consultant.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Component part 03.037.004, lot 160236-201 was received.Part 03.037.004, lot 160236-201: manufacturing site: selzach.Supplier: leitner ag.Release to warehouse date: august 29, 2016.A manufacturing record evaluation was performed for the finished device lot number, and no non-conformances were identified.A product investigation was completed: visual inspection identified that the nitinol spring component on the centering attachment sub-assembly is missing.The weld that secured the spring to the body has failed.The relevant drawings were reviewed.No product design issues or discrepancies were observed during this investigation.A relevant dimensional inspection is not possible for the conditions of a failed weld and missing spring.A definitive root cause for the missing spring could not be determined based on the provided information.This complaint is confirmed however no product design issues or manufacturing discrepancies that would contribute to the reported complaint condition were identified during this investigation.No new, unique or different patient harms were identified as a result of this evaluation.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post market safety surveillance activities.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|